Predicting the Effects of Nonspecific Channel Blocking Drugs has Variable Success Rates Between Different Ventricular Myocyte Action Potential Models  by McGovern, Kathleen R. & Sobie, Eric A.
Tuesday, February 28, 2012 541ainactivation as well as a slowing of Ina recovery was observed for R811H.
NaV1.5-R620H had no significant effect on the current. Proband 2, 33 year-
old male with history of recurrent syncope which occurred both at rest and
with exercise, had a novel NaV1.5-S1218I mutation. NaV1.5-S1218I had com-
plete loss-of-function, and 1:1 expression of NaV1.5-WT and NaV1.5-S1218I
mimicking the heterozygous state, revealed a 50% reduction of current com-
pared to WT suggesting a functional haploinsufficiency in the patient.
CONCLUSION: NaV1.5-S1218I and R811H are novel loss-of-function muta-
tions in the SCN5A gene causing Brugada syndrome, whereas R620H did not
appear to alter NaV1.5 function.
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The late sodium current [INa,late] can play an important role in generating ar-
rhythmogenic afterdepolarisations in cardiac myocytes. However the profile
of INa,late during the action potential [AP] has not yet been directly measured.
The goal of the present study was to directly record and describe the profile of
INa,late as it could be observed in situ (in a physiological milieu, during AP, with
undisturbed cellular calcium homeostasis).
METHODS: Our newly developed ‘Onion-Peeling’ technique (a variant of ac-
tion potential voltage-clamp) was utilised to dissect out INa,late during AP by
using tetrodotoxin. The experiments were done on isolated guinea pig ventric-
ular myocytes at 36 C. In one set of experiments no exogenous calcium buffer
was used in the internal solution, which enabled intracellular calcium cycling
during AP. In the other set of recordings intracellular calcium concentration
was clamped with BAPTA. The intracellular calcium concentration was mea-
sured by using Fura-2.
RESULTS: The tetrodotoxin-sensitive current first displayed a large peak dur-
ing the AP upstroke attributable to the fast sodium current, and then showed
a sustained current throughout the AP due to INa,late. With cycling calcium,
INa,late showed a gradual increase during the AP plateau phase and then peaked
during the fast repolarising phase. When the intracellular calcium was clamped,
INa,late showed larger current density throughout the AP time course but the
overall current profile remained similar.
CONCLUSION: The INa,late profile directly recorded in situ by using the ‘On-
ion-Peeling’ method is different from what previously predicted by model sim-
ulations based on the data obtained using conventional voltage-clamp under
simplified conditions (ion substitution, calcium buffering, rectangular voltage
pulses). The observed high INa,late density during the AP repolarising phase un-
derlies the arrhythmogenic role of the current.
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Pro-arrhythmic changes to ventricular action potential (AP) duration (APD)
are one of the most frequent causes for the removal or restriction of mar-
keted drugs and are difficult to predict a priori. A common link between
all arrhythmogenic drugs is block of the rapid delayed rectifier channel
(a.k.a. the hERG channel), but many hERG-blocking drugs also affect ad-
ditional ion transport pathways. These nonspecific effects can attenuate or
exacerbate a drug’s arrhythmogenic risk and greatly alter the drug-induced
changes to APD. Using mathematical models of ventricular myocytes, we
sought to determine whether the effects of a nonspecific drug could be pre-
dicted from the effects of pure channel-blocking drugs. In several models,
we simulated a hypothetical specific hERG-blocking drug, drugs that spe-
cifically blocked every other ion transport pathway (10-20 in each model),
and each combination of block of hERG plus an additional pathway. The
response to each hypothetical drug was expressed as a dose response
curve, with log([drug]) on the abscissa and log(APD/APDnodrug) on the or-
dinate. In a popular mathematical of the human ventricular myocyte, we
found that the response to a nonspecific drug could be predicted with
a high degree of accuracy by summing the dose-response curves of the
specific drugs. This indicates that the pathways affected by uncharacterized
compounds can be deduced from dose-response data. In a common model
of the canine ventricular myocyte, however, summing the specific drugs’dose-response curves generally failed to approximate the dose-response
curve of the corresponding nonspecific drug. This result points to important
differences between models, and has implications for the prediction of non-
specific effects during the drug development process.
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Background
Compared to young adult rat hearts, aged rat hearts exhibit marked fibrosis and
increased susceptibility to ventricular tachycardia and fibrillation (VT/VF)
when exposed to oxidative and ionic stress.
Objective
To evaluate the contributions of aging-related structural tissue changes (fibro-
sis) vs. cellular electrophysiological properties in the increased arrhythmia risk
of aged ventricles, we exposed intact hearts and single myocytes from aged and
young adult rats to oxidative stress with angiotensin II (ATII) or ionic stress
with hypokalemia and assessed for occurrences of VT/VF and their triggers.
Methods & Results
Trichrome staining revealed markedly more fibrosis in ventricular tissue from
aged than from young adult rats (385 12% vs. 2.05 0.6%, P < 0.01). In in-
tact hearts, ATII (2 mM) caused spontaneous early afterdepolarization (EAD)-
mediated triggered activities that degenerated to VT/VF in 16/19 (83%) aged
hearts after a mean exposure of 32 5 7 min, but in none (0/9 or 0%) of the
young adult hearts. Hypokalemia (2.7mM) caused EAD-mediated VT/VF in
all aged hearts (11/11 or 100%) after a mean exposure of only 7.4 5 0.4
min and in 8/14 (57%) young adult hearts but with delayed onset of up to 31
5 22 min (P < 0.05). In isolated myocytes, ATII induced EADs, DADs,
and triggered activity in patch-clamped isolated ventricular myocytes from
both age groups. Similarly, hypokalemia induced EADs in single myocytes
from both age groups at slow pacing cycle lengths (> 4s), but only in aged my-
ocytes at more rapid pacing cycle lengths (1-3 s)
Conclusion
Fibrosis plays a central role in the increased vulnerability of aged hearts to VT/
VF during ATII or hypokalemia exposure, although aging-related cellular elec-
trophysiological changes may contribute modestly.
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Early afterdepolarizations (EADs) are transient reversals of repolarization that
are known triggers for fatal cardiac arrhythmias such as ventricular fibrillation.
Our previous work, using dynamic clamp, demonstrated that EADs are very
sensitive to the steady-state biophysical properties of ICa,L, which determine
its ‘‘window current’’ features. The dynamic clamp is a technique that inte-
grates mathematical modeling and electrophysiology in real time, allowing
the injection of current with time- and voltage-dependent properties determined
by tunable parameters. Using this approach, we sought to understand the rele-
vance of ICa,L kinetics in EAD formation and suppression. Upon inducing
EADs with 0.6 mM H2O2, we blocked the native ICa,L with 20 mM nifedipine
and replaced it with a dynamically-generated ICa,L in dissociated rabbit ventric-
ular myocytes and reconstituted EADs in>70% of action potentials (APs). We
then altered the time constants of ICa,L activation and inactivation. We found
that increasing or decreasing the rate of activation by up to 10-fold had a modest
effect on EAD suppression, but EAD amplitude decreased as the activation rate
was increased. Conversely, increasing the rate of inactivation exacerbated EAD
occurrence, such that 85% of APs exhibited EADs and a dramatically pro-
longed APD90, to 24465193 ms. Reducing the inactivation rate by half, sup-
pressed EAD occurrence such that <30% of APs showed EADs, although
APD90 remained slightly prolonged at 713568 ms. Interestingly, in the
same cell both EAD occurrence and APD90 appear more sensitive to small
changes in the voltage-dependence properties of ICa,L such that EADs were
completely abolished and APD90 was restored to 25759 ms. Thus, while
ICa,L kinetics play a role in EAD genesis, the steady-state biophysical properties
of ICa,L are a more effective therapeutic target for EAD suppression. Supported
by AHA & NIH/NHLBI.
